Third annual All Nations Saint Patrick’s Day Parade, 10 a.m., downtown Rapid City. This year's parade supports Oglala Pet ...

KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will ...

Versar is a defense contracting and project management company headquartered in Springfield, Virginia. Its team specializes in engineering and construction, environmental services, professional ...

Editas Medicine EDIT reported a loss of 55 cents per share in the fourth quarter of 2024, wider than the Zacks Consensus ...

Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...

This decrease was primarily attributable to revenue recognized from the upfront payment under the Company’s license agreement with Vertex executed in December 2023. Research and development expenses ...

Find out what's up in your night sky during January 2025 and how to see it in this Space.com stargazing guide. Looking for a telescope for the next night sky event? We recommend the Celestron ...

Both are developed in partnership with Vertex. Another application of CRISPR Therapeutics ... as it is investing a little more than its total current revenues ($81M in Q1 2023) in R&D. The company ...

Light will blind you in your search for answers, dark will make them shine. May the dark be kinder on thine eyes. (DuckDuckGo dark theme) ...

Stifel pointed out that during Vertex’s last major investment cycle from mid-2021 to mid-2023, the stock remained range-bound in the low $20s, with ARR growth steady but not accelerating.

During Florida Institute of Technology President John Nicklow's interview activities leading up to his April 2023 hiring ... and Innovative Design as Vertex, a new "applied innovation hub." ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...